Rheumatools

jle.rheumatools

View detailed information for Rheumatools — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
10.2K(10,237)
Rating
0.0
Released
November 28, 2017
Last updated
January 1, 1970
Category
Medical
Developer
SAS JLE
Developer details
Name
SAS JLE
E-mail
i-app@jle.com
Website
unknown
Country
France
Address
unknown
Rheumatools Header - AppWisp.com

Screenshots

Rheumatools Screenshot 1 - AppWisp.com
Rheumatools Screenshot 2 - AppWisp.com
Rheumatools Screenshot 3 - AppWisp.com
Rheumatools Screenshot 4 - AppWisp.com

Description

This application will assist you in the various stages of the care of your patient. Divided into six sections comprehensive, it provides indispensable tools: Interactive scores, fact sheets, summary tables, updated recommendations, photos and criteria diagnostic pathology.

This medical application is for healthcare professionals that support bone and joint diseases and systemic diseases.

The objective of this application is to assist the healthcare professional in their daily practice.

Several groups of tools are available:
- Diagnostic criteria and classifications of key inflammatory rheumatism, systemic diseases, microcrystalline conditions but also mechanical pathologies.
- pretreatment Balances of biological and synthetic antirheumatic and bisphosphonates.
- Dosages of the main therapeutic (DMARDs, NSAIDs, corticosteroids, antiosteoporotic etc ...) in rheumatology according to the different pathologies.
- treatments Supervision Orders biological and synthetic antirheumatic.
- The different business Scores of inflammatory rheumatism and systemic diseases and the FRAX score and other calculations of corrected calcium, BMI or body surface.
- Infiltration: methods for carrying infiltratifs gestures with benchmarks, technical and managements anticoagulant / antiplatelet agents.
 No data on the patient's identity is stored in the application or on a remote server.

This medical application was scientifically coordinated by:

· Doctor Baptiste Coustet, Rheumatology, CHU Bichat-Claude Bernard, Paris
· Professor Philippe Dieudé, Rheumatology, CHU Bichat-Claude Bernard, Paris
· Dr. Sébastien Ottaviani, Rheumatology, CHU Bichat-Claude Bernard, Paris.